Literature DB >> 8140041

Bioavailability of flumequine after semisimultaneous administration to veal calves.

B A Meijer1, K G Ceyssens, W T de Jong, B I de Grève.   

Abstract

The absolute bioavailability of flumequine after semisimultaneous intramuscular administration as a water-based suspension to veal calves was 92 +/- 14%. The semisimultaneous experimental design provided a reliable determination of absorption rate and demonstrated flip-flop pharmacokinetics. No period or sequence effects were detected. Calculated elimination rate, clearance, and volume of distribution after intravenous administration were comparable to values obtained from traditional design studies. The semisimultaneous experimental design proved to be valuable for the assessment of bioavailability and pharmacokinetics of drugs in food-producing animals while preventing violation of basic clearance assumptions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8140041     DOI: 10.1023/a:1018962131274

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  12 in total

1.  Half-life and volume of distribution of trimethoprim and sulphadoxine in sheep and its relation to age and weight.

Authors:  M Atef; S A Al-Samarrae; Y M Abdel Hamio
Journal:  Zentralbl Veterinarmed A       Date:  1979-01

2.  Comparison of methods to calculate cyclosporine A bioavailability from consecutive oral and intravenous doses.

Authors:  M O Karlsson; A Lindberg-Freijs
Journal:  J Pharmacokinet Biopharm       Date:  1990-08

3.  On the assessment of bioequivalence in a two-period cross-over design.

Authors:  H P Wijnand
Journal:  Comput Methods Programs Biomed       Date:  1992-03       Impact factor: 5.428

4.  Pharmacokinetics, metabolism and renal clearance of flumequine in veal calves.

Authors:  D J Mevius; H J Breukink; P J Guelen; T Jansen; B De Grève
Journal:  J Vet Pharmacol Ther       Date:  1990-06       Impact factor: 1.786

5.  Bioavailability estimation by semisimultaneous drug administration: a Monte Carlo simulation study.

Authors:  M O Karlsson; U Bredberg
Journal:  J Pharmacokinet Biopharm       Date:  1990-04

6.  The application of stable isotopes to studies of drug bioavailability and bioequivalence.

Authors:  R L Wolen
Journal:  J Clin Pharmacol       Date:  1986 Jul-Aug       Impact factor: 3.126

7.  Estimation of absolute bioavailability assuming steady state apparent volume of distribution remains constant.

Authors:  P S Collier; S Riegelman
Journal:  J Pharmacokinet Biopharm       Date:  1983-04

8.  Clinical pharmacokinetics of flumequine in calves.

Authors:  G Ziv; S Soback; A Bor; B Kurtz
Journal:  J Vet Pharmacol Ther       Date:  1986-06       Impact factor: 1.786

9.  Age-dependent pharmacokinetics of oxytetracycline in ruminants.

Authors:  J F Nouws; C A van Ginneken; G Ziv
Journal:  J Vet Pharmacol Ther       Date:  1983-03       Impact factor: 1.786

10.  Clinical pharmacology and pharmacokinetics of flumequine after intravenous, intramuscular and oral administration in pigeons (Columba livia).

Authors:  G M Dorrestein; H van Gogh; M N Buitelaar; J F Nouws
Journal:  J Vet Pharmacol Ther       Date:  1983-12       Impact factor: 1.786

View more
  2 in total

Review 1.  Flip-flop pharmacokinetics--delivering a reversal of disposition: challenges and opportunities during drug development.

Authors:  Jaime A Yáñez; Connie M Remsberg; Casey L Sayre; M Laird Forrest; Neal M Davies
Journal:  Ther Deliv       Date:  2011-05

2.  Flumequine in the goat: pharmacokinetics after intravenous and intramuscular administration.

Authors:  R Villa; P Cagnardi; O Sonzogni; S Carli
Journal:  Vet Res Commun       Date:  2005-11       Impact factor: 2.459

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.